Navigation Links
Lilly, Covance Strategic Alliance Proves Win-Win For Both Companies, Patients
Date:2/26/2010

  • Lilly has reduced its fixed costs by making some of them variable – an example of Lilly's FIPNet strategy to become more flexible and collaborative.

  • In addition to the services provided to Lilly, Covance has provided R&D services to approximately 20 other biopharmaceutical companies in Greenfield, enabling the company to further invest and grow the campus.

"These milestones demonstrate that this strategic alliance is already a win-win for both Covance and Lilly," said Covance CEO Joe Herring. "In the first year, we've proven that we can help accelerate drug development timelines and improve efficiencies, enabling Lilly to focus on its core competencies in delivering better patient outcomes over the longer-term. The positive, collaborative working relationships between Lilly and Covance employees have been equally impressive."

"The passion
'/>"/>

SOURCE Covance Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Alexandria Real Estate Equities, Inc. Signs Biopharmaceutical Company, Lilly, as Anchor New York City Tenant at the Alexandria Center for Science and Technology
2. Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2007 Financial Results Conference Call
3. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
4. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
5. Covance to Present at The R.W. Baird 2008 Growth Stock Conference
6. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
7. Covance Decides to Pursue Its Original Preclinical Strategy in China
8. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
9. Covance Purchases Equity Stake in Caprion Proteomics
10. Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
11. Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... , ... Proove Biosciences, Inc. is a finalist for the Outstanding Tech Company ... Now in its 22nd year, this premier awards event celebrates the best in Orange ... around the world. The OC Tech Alliance will announce all winners at a gala ...
(Date:8/28/2015)... -- According to a new market research ... Thawing Equipment, Alarms), by Biospecimen (Human Tissue, Stem Cells, ... - Global Forecast to 2020", published by MarketsandMarkets, the ... Million by 2020 from USD 2,150.48 Million in 2015, ... 2020. Browse 74 Tables and 95 ...
(Date:8/28/2015)... VANCOUVER , Aug. 28, 2015 /PRNewswire/ - ... clinical stage regenerative medicine company focused on the ... results for the quarter ended June 30, 2015, ... statements and management report are available at ... www.replicel.com . "RepliCel expects to ...
(Date:8/27/2015)... ... August 27, 2015 , ... The Kansas ... investment firms and animal health companies to hear from animal health companies with ... have also received licensing agreements or distribution contracts. This meeting is one ...
Breaking Biology Technology:Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 2Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 3Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 4Biopreservation Market Worth 3,731.03 Million USD by 2020 2Biopreservation Market Worth 3,731.03 Million USD by 2020 3Biopreservation Market Worth 3,731.03 Million USD by 2020 4Biopreservation Market Worth 3,731.03 Million USD by 2020 5RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3
... PRINCETON, N.J., Feb. 5 Celator Pharmaceuticals today,announced ... scheduled,to present on the company,s business operations and ... Organization (BIO) CEO,and Investor Conference on Tuesday, February ... New York City., About Celator, Celator ...
... (OTC Bulletin Board: NILT), announced today that Peter M. ... & Investor Conference,at the Waldorf-Astoria Hotel in New York ... Mr. Strumph will provide an overview of Nile and ... will be webcast live and can be accessed by ...
... Collections to Begin at ProHEALTH Facility by End of ... Inc. (Amex: NBS ),which is pioneering the pre-disease ... future medical need, today announced,receipt of a provisional license ... stem cells from the New York State,Department of Health ...
Cached Biology Technology:Nile Therapeutics, Inc. to Present at Upcoming BIO CEO & Investor Conference 2NeoStem Announces NY State License for Adult Stem Cell Collection 2NeoStem Announces NY State License for Adult Stem Cell Collection 3
(Date:7/31/2015)... China , 31 de julho de 2015 /PRNewswire/ ... (ICG-10, www.icg-10.org ) será realizada pela BGI de 22-25 ... . A conferência está celebrando seu ... em 2006, a ICG se tornou uma das reuniões ... um dos encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... julio de 2015 La 10 th International ... medio de BGI del 22 al 25 de octubre de 2015 ... Este año, la conferencia celebra su décimo aniversario. Desde su ... una de las reuniones anuales más influyentes del mundo en ... más dinámicas, entusiastas y mejores a nivel científico. ...
(Date:7/31/2015)... 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market and creator of ... provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY MANAGEMENT ... method to advance crypto-currencies such as Bitcoin into the ... uniform way to manage all payments.  ...
Breaking Biology News(10 mins):A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
... fat capsules, often added to beauty products. According ... active ingredients deep into the skin and release the ... structure by rejuvenating and smoothing the skin. ... liposomes are not capable of transporting themselves deep into ...
... Organic rice studies have moved to the front burner ... AgriLife Research scientists. Two studies, led by Dr. Fugen ... Station, Corpus Christi, Arkansas, Alabama and South Carolina will ... environmentally friendly way. The research projects are funded by the ...
... Raman spectroscopy has enabled incredible advances in ... for tissue classification and disease recognition, although there ... in a clinical setting. Scientists have now demonstrated ... door to wider biomedical and clinical applications such ...
Cached Biology News:Don't trust liposomes in your beauty products 2Organic rice research moves to front burner in Texas 2Breakthrough study opens door to broader biomedical applications for Raman spectroscopy 2
Rabbit anti-phospho-EGFr (Tyr992) - Concentrate...
... Clone/PAD: PS603. Immunogen: ... region surrounding the phosphorylated Ser603 ... Specificity: Specific for synapsin ... (site 3). Reactivity: Rat ...
CMRL Medium-1066 (1X) liquid...
... 11(R)-HETE is biosynthesized by the ... purpuratus, and the fresh water hydra, ... 11(R)-HETE relates to oocyte maturation and ... species.11(R)-HETE is also produced when aspirin-treated ...
Biology Products: